A digital coach for the heart: app aims to keep risk factors in check after a heart attack

NCT ID NCT07720349

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app called HeartCheck can help people who have recently survived a heart attack better manage their blood pressure, cholesterol, blood sugar, and smoking habits. The app provides education, reminders, and easy-to-understand goals to support medication adherence and lifestyle changes. Researchers will compare outcomes between app users and those receiving standard follow-up care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a smartphone app called HeartCheck that provides education, reminders, and goal tracking for heart attack survivors
What this could lead to
If it works, this could offer a simple, scalable way to help heart attack survivors keep their blood pressure, cholesterol, and other risk factors under control.
What could go wrong
This is a single-center trial testing a new app, so results may not apply broadly. Success depends on patients actually using the app consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oslo University Hospital Ullevål

    RECRUITING

    Oslo, Norway

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sørlandet Hospital Arendal

    RECRUITING

    Arendal, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.